JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on September 3, 2004; DOI: 10.1124/jpet.104.072686


0022-3565/05/3121-309-315$20.00
JPET 312:309-315, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.072686v1
312/1/309    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Melichar, J. K.
Right arrow Articles by Nutt, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Melichar, J. K.
Right arrow Articles by Nutt, D. J.

NEUROPHARMACOLOGY

Using [11C]Diprenorphine to Image Opioid Receptor Occupancy by Methadone in Opioid Addiction: Clinical and Preclinical Studies

Jan K. Melichar, Susan P. Hume, Tim M. Williams, Mark R. C. Daglish, Lindsay G. Taylor, Rabia Ahmad, Andrea L. Malizia, David J. Brooks, Judith S. Myles, Anne Lingford-Hughes, and David J. Nutt

Psychopharmacology Unit, University of Bristol, Bristol, United Kingdom (J.K.M., T.M.W., M.R.C.D., L.G.T., A.L.M., A.L.H., D.J.N.); Hammersmith Imanet Ltd., Hammersmith Hospital, London, United Kingdom (S.P.H., R.A.); Medical Research Council Clinical Sciences Centre and Division of Neuroscience, Faculty of Medicine, Imperial College, Hammersmith Hospital, London, United Kingdom (D.J.B.); and Bristol Specialist Drug Service, Blackberry Hill Hospital, Bristol, United Kingdom (J.S.M.)

Substitute methadone prescribing is one of the main modes of treatment for opioid dependence with established evidence for improved health and social outcomes. However, the pharmacology underpinning the effects of methadone is little studied despite controversies about dosing in relation to outcome. We therefore examined the relationship between methadone dose and occupation of opioid receptors in brain using the positron emission tomography (PET) radioligand [11C]diprenorphine in humans and rats. Eight opioid-dependent subjects stable on their substitute methadone (18-90 mg daily) had an [11C]diprenorphine PET scan at predicted peak plasma levels of methadone. These were compared with eight healthy controls. No difference in [11C]diprenorphine binding was found between the groups, with no relationship between methadone dose and occupancy. Adult male Sprague-Dawley rats that had been given an acute i.v. injection of methadone hydrochloride (0.35, 0.5, 0.7, or 1.0 mg kg-1) before [11C]diprenorphine showed a dose-dependent increase in biodistribution but no reduction in [11C]diprenorphine binding. We suggest that the lack of a dose-dependent relationship between methadone dose, either given chronically in human or acutely in rat, and occupancy of opioid receptor measured with [11C]diprenorphine PET is related to efficacy of this opioid agonist at very low levels of opioid receptor occupancy. This has implications for understanding the actions of methadone in comparison with other opioid drugs such as partial agonists and antagonists.


Received for publication June 14, 2004
Accepted September 1, 2004.

Address correspondence to: Professor David J. Nutt, Psychopharmacology Unit, University of Bristol, Dorothy Hodgkin Building, Whitson St., Bristol, BS1 3NY, UK. E-mail: david.j.nutt{at}bristol.ac.uk




This article has been cited by other articles:


Home page
BrainHome page
G. Henriksen and F. Willoch
Imaging of opioid receptors in the central nervous system
Brain, May 1, 2008; 131(5): 1171 - 1196.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
B. Adinoff
Divided Doses for Methadone Maintenance
Am J Psychiatry, March 1, 2008; 165(3): 303 - 305.
[Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. P. Hume, A. R. Lingford-Hughes, V. Nataf, E. Hirani, R. Ahmad, A. N. Davies, and D. J. Nutt
Low Sensitivity of the Positron Emission Tomography Ligand [11C]Diprenorphine to Agonist Opiates
J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 661 - 667.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
T. M. Williams, M. R. C. Daglish, A. Lingford-Hughes, L. G. Taylor, A. Hammers, D. J. Brooks, P. Grasby, J. S. Myles, and D. J. Nutt
Brain opioid receptor binding in early abstinence from opioid dependence: Positron emission tomography study
The British Journal of Psychiatry, July 1, 2007; 191(1): 63 - 69.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.